SCHEMBL23904233

SCHEMBL23904233

N=Cc1cc(Nc2ccc(F)cc2)c(Br)cc1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
PRKD3 O94806 1/20 0.36
EGFR P00533 1/20 0.36
PRKCG P05129 1/20 0.36
PRKCB P05771 1/20 0.36
SRC P12931 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCH P24723 1/20 0.36
PRKCI P41743 1/20 0.36
PRKCE Q02156 1/20 0.36
PRKCQ Q04759 1/20 0.36
PRKCZ Q05513 1/20 0.36
PRKCD Q05655 1/20 0.36
PRKD1 Q15139 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
SOS1 Q07889 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26045155 0.95 MAPT (0.36) MAPTMEN1KMT2APRKD3EGFR
SCHEMBL21901147 0.75 MEN1 (0.30) MAPTMEN1KMT2APRKD3EGFR
SCHEMBL22828956 0.75 TDP1 (0.40) MAPTMEN1KMT2APRKD3EGFR
SCHEMBL26495850 0.75 MAPT (0.41) MAPTMEN1KMT2APRKD3EGFR
SCHEMBL20036833 0.75 MAPT (0.41) MAPTMEN1KMT2APRKD3EGFR
SCHEMBL25794401 0.75 KMT2A (0.36) MAPTMEN1KMT2APRKD3EGFR
SCHEMBL24283166 0.73 MAPK10 (0.37) MAPTMEN1KMT2APRKD3EGFR
SCHEMBL20418690 0.73 KDM1A (0.33) MAPTKMT2AKCNH2
SCHEMBL25804586 0.72 ACP1 (0.38) MAPTMEN1KMT2APRKD3EGFR
SCHEMBL24152911 0.72 TDP1 (0.39) MAPTMEN1KMT2APRKD3EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021203010-A1 PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-10-07 WO disclosed